terbutaline has been researched along with Myasthenic Syndromes, Congenital in 1 studies
Terbutaline: A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.
terbutaline : A member of the class of phenylethanolamines that is catechol substituted at position 5 by a 2-(tert-butylamino)-1-hydroxyethyl group.
Myasthenic Syndromes, Congenital: A heterogeneous group of disorders characterized by a congenital defect in neuromuscular transmission at the NEUROMUSCULAR JUNCTION. This includes presynaptic, synaptic, and postsynaptic disorders (that are not of autoimmune origin). The majority of these diseases are caused by mutations of various subunits of the nicotinic acetylcholine receptor (RECEPTORS, NICOTINIC) on the postsynaptic surface of the junction. (From Arch Neurol 1999 Feb;56(2):163-7)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyana, K | 1 |
| Ishiyama, A | 1 |
| Saito, Y | 1 |
| Nishino, I | 1 |
1 other study available for terbutaline and Myasthenic Syndromes, Congenital
| Article | Year |
|---|---|
Tulobuterol is a potential therapeutic drug in congenital myasthenic syndrome.
Topics: Adrenergic beta-2 Receptor Agonists; Humans; Myasthenic Syndromes, Congenital; Terbutaline | 2022 |